Seroprevalence and Potential Risk Factors of Toxocariasis among General Population in Southwest Iran: Implications on the One Health Approach

Table 2

Clinical symptoms associated with toxocariasis in general population from Abadan and Khorramshahr cities (Khuzestan Province, southwest Iran).

Variable	No. of tested (%)	Seroprevalence		OR (95% CI)	p value
		%	95% CI
Asthma
Yes	93 (25.6%)	27 (29.0%)	20.78–38.94	5.26 (2.86–10.0)
No	270 (74.4%)	19 (7.0%)	4.55–10.73	0.19 (0.10–0.35)	<0.001
Skin allergic disorders
Yes	102 (28.1%)	30 (29.4%)	21.44–38.87	6.25 (3.33–12.50)
No	261 (71.9%)	16 (6.1%)	3.81–9.72	0.16 (0.08–0.30)	<0.001
Ophthalmic disorders or blurred vision
Yes	77 (21.2%)	34 (44.2%)	33.60–55.26	16.67 (9.09–33.33)
No	286 (78.8%)	12 (4.2%)	2.42–7.19	0.06 (0.03–0.11)	<0.001
Epilepsy
Yes	15 (4.1%)	3 (20.0%)	7.05–45.18	1.79 (0.48–6.67)
No	348 (95.9%)	43 (12.4%)	9.30–16.23	0.56 (0.15–2.08)	0.390

OR, odds ratio; CI, confidence interval.